Active — Not RecruitingPhase 4

Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

South Korea88 participantsStarted 2023-08-21

Plain-language summary

A multicenter, randomized, double-blind, phase Ⅳ study to evaluate the long-term efficacy and safety of Pitavastatin/Ezetimibe and Pitavastatin in patients with hypercholesterolemia with elevated triglycerides

Who can participate

Age range19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with hypercholesterolemia * Patients diagnosed with metabolic syndrome or type 2 diabetes mellitus, and presenting with elevated LDL-C Exclusion Criteria: * New-onset acute cardio-cerebrovascular disease * Severe hepatic impairment * Active liver disease

What they're measuring

Percentage change from baseline in LDL Cholesterol at Week 8 after the first dose of study treatment

Timeframe: Baseline to week 8

Trial details

NCT IDNCT07442630

SponsorJW Pharmaceutical

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-01-22

View on ClinicalTrials.gov More Hypercholesterolemia trials